FDA Inspection
Cipla LimitedCipla Limited – FDA Inspection, Nov 2, 2012
Record Details
This FDA Inspection record concerns Cipla Limited, with an inspection on November 2, 2012, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Cipla Limited
- Inspection Date
- November 2, 2012
- Product Type
- Drugs
View Company Profile
ID · 78379ee7-9bf8-4cc2-977e-c2560781fac2
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 806838
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Cipla Limited
8| Date | Classification | Office | Project area |
|---|---|---|---|
| August 25, 2026 | Not classified | Office of Inspections and Investigations | |
| February 17, 2023 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 17, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 13, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 23, 2017 | Not classified | Office of Inspections and Investigations | Generic Drug Evaluation |
Other documents for Cipla Limited
- FDA Inspection 1331746 - 2026-08-25
- FDA Inspection 1198343 - 2023-02-17
- FDA Inspection 1094880 - 2019-05-17
- FDA Inspection 1048005 - 2018-04-13
- FDA Inspection 1019068 - 2017-06-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.